13
Participants
Start Date
December 31, 2005
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
Imatinib
800 mg/day until disease progression or toxicity
Centre Francois Baclesse, Caen
Centre Georges-Francois Leclerc, Dijon
Institut Claudius Regaud, Toulouse
Centre Val d'Aurelle Paul Lamarque, Montpellier
Centre Oscar Lambret, Lille
Centre Hospitalier Regional Universitaire, Lille
Centre Jean Perrin, Clermont-Ferrand
Centre Paul Strauss, Strasbourg
Hopital Universitaire de Hautepierre, Strasbourg
Centre Leon Berard, Lyon
Institut Curie, Paris
Centre Gustave Roussy, Villejuif
Collaborators (1)
Novartis
INDUSTRY
National Cancer Institute, France
OTHER_GOV
Centre Oscar Lambret
OTHER